Raising the Bar for PAH Treatment: Treating to Low Risk

Join host Corinne Young and guest expert Melisa Wilson for a practical deep-dive on pulmonary hypertension (PH). They dive deep into what “treating to low risk” really means, how to use risk calculators (e.g., REVEAL 2.0, mini/light tools) between visits, and when to escalate therapy to improve outcomes. Hear actionable tips on risk stratification, frequent follow-ups, patient engagement, side-effect planning, and aggressive afterload reduction to optimize RV function—all aimed at driving patients from intermediate/high risk to low-risk survival profiles. Subscribe for more PH education and clinician-focused insights.
https://youtu.be/_R6DJCRfjT0?si=UWmcSykeYktxscUF

By Lori - November 26, 2025

Journal Club: Practical Considerations for Tyvaso DPI

Join Lori Reed, MSN, APRN, FNP-C, from Piedmont Healthcare, as she discusses practical considerations for managing patients on Tyvaso DPI.

By Susanne - November 26, 2025

Medication Review: Clinical Pearls for PAH & PH-ILD Management with Tyvaso DPI

Join Susanne McDevitt, DNP, ACNP-BC, from the University of Michigan School of Nursing, in a discussion regarding the clinical pearls for PAH and PH-ILD Management with Tyvaso DPI.

By Susanne - November 26, 2025

FAQ: How Does Aggressive Afterload Reduction in PAH Contribute to Right Ventricular Reverse Remodeling and Improved Clinical Outcomes?

Join Susanne McDevitt, DNP, ACNP-BC, from the University of Michigan School of Nursing, in a discussion regarding how aggressive afterload reduction in PAH contributes to right ventricular reverse remodeling and improved clinical outcomes.

Your Pulmonology Education, Personalized. Anytime. Anywhere.

Join the APAPP community, customize your learning, and connect with peers to elevate patient care.